International Journal of Biological Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2024-11-19 缅怀21世纪来自四川省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？

26 0

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2024-10-28 ms1000001760489592 来自湖北省

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：3.14 投稿
4.9 大修
6.19 返修，提交原始图像
6.21 条件性接收
6.23 缴费，提交图形摘要，最终版文稿、figure
6.29 proof
7.1 online
效率很高的杂志，主编非常负责，审稿人友好、专业细致

11 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2023-08-18 ms2000000311873048 来自湖南省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。

69 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2024-10-22 ms1000002113223257 来自山东省

偏重的研究方向：肿瘤
经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了

11 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2024-09-02 1891e859aem 来自广东省

偏重的研究方向：分子生物学;医学;凋亡
经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审

31 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2024-09-24 541350208 来自重庆

目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2024-10-30 541350208 来自重庆

即时影响因子接近8分，今年保9冲10

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2023-02-15 lidndffdgfdgfdg 来自重庆

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：干细胞;基因功能;肿瘤表观遗传
经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.#期刊论坛#

147 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2022-12-12 1476a8ddm35暂无昵称来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：炎症
经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01
动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。

96 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237761, encodeId=f1e1223e76184, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Conditional acceptance后，我上传了图形摘要，高清图片，最终稿件，交了版面费后我只收到了缴费的邮件，我文件收到的邮件没有，怎么知道他们收到了我的最终文件和图片啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Tue Nov 19 11:30:59 CST 2024, time=2024-11-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233656, encodeId=d4a5223365644, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：3.14 投稿 4.9 大修 6.19 返修，提交原始图像 6.21 条件性接收 6.23 缴费，提交图形摘要，最终版文稿、figure 6.29 proof 7.1 online 效率很高的杂志，主编非常负责，审稿人友好、专业细致, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bad8649258, createdName=ms1000001760489592, createdTime=Mon Oct 28 12:07:41 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153492, encodeId=73392153492b6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：恶心人的期刊，第一次投2周左右说因为没有找到审稿人就给拒了。然后和编辑battle也没有回信就再投了，这次状态变了但是没给送审又给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Fri Aug 18 23:35:39 CST 2023, time=2023-08-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232305, encodeId=94c4223230513, content=偏重的研究方向：肿瘤 经验分享：记录一下投稿过程 2024.10.20-提交突然发现这个杂志CAR指数好高，会不会有被踢风险啊，有点害怕，B&P都被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210317/f0c95179a35b408c9ca61721649b6f9e/ec3c8babfe2d4b7a9d33693f09273108.jpg, createdBy=5dac5444550, createdName=ms1000002113223257, createdTime=Tue Oct 22 00:35:28 CST 2024, time=2024-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223626, encodeId=512f2223626cd, content=偏重的研究方向：分子生物学;医学;凋亡 经验分享：2024-08-25 投稿，当天active 2024-08-30 replace消失，期待送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Sep 02 07:52:07 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227389, encodeId=5a26222e38908, content=目前即时影响因子接近7分，今年有机会保9争10，兄弟引用起来啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Tue Sep 24 11:46:05 CST 2024, time=2024-09-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2234170, encodeId=6a2122341e0a6, content=即时影响因子接近8分，今年保9冲10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e94b3000085, createdName=541350208, createdTime=Wed Oct 30 19:09:45 CST 2024, time=2024-10-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114814, encodeId=cb6c21148148d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;基因功能;肿瘤表观遗传 经验分享：2022.11.15投稿，202212.24.小修. 2023.01.07修回. 2023.02.07再小修. 2023.02.14修回.2023.02.15接收。需要提供WB全膜图供审稿参考，文章用的WB.<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed395579741, createdName=lidndffdgfdgfdg, createdTime=Wed Feb 15 22:15:08 CST 2023, time=2023-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231324, encodeId=b0822231324c2, content=international journal of biological sciences怎么看是否已提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18de8624809, createdName=ms4000000893917564, createdTime=Thu Oct 17 12:55:03 CST 2024, time=2024-10-17, status=1, ipAttribution=重庆)]

2024-10-17 ms4000000893917564 来自重庆

international journal of biological sciences怎么看是否已提交

16 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务